The antibiotics
field guide.
Every drug your textbook recommends — grouped by class, mapped to bugs, with the hierarchy it gives them. Built so the name ceftriaxone on a page fires cephalosporin → cell-wall → 3rd-gen → DOC for gonorrhoea & meningitis in one beat.
§ 01The five-family map
Every antibiotic in the book lives in one of five mechanism families. Once a drug's family is in your head, its spectrum and toxicity follow logically. Internalise these five and the rest is just sub-categories.
Family 1
Cell wallStop peptidoglycan being built. Bacterium bursts from osmotic pressure. β-lactams + glycopeptides. Bactericidal. Useless against wall-less bugs (Mycoplasma).
Family 2
Protein synthesisHit the ribosome — 30S (aminoglycosides, tetracyclines) or 50S (macrolides, clindamycin, chloramphenicol, linezolid). Mostly bacteriostatic — except aminoglycosides which are -cidal.
Family 3
Nucleic acidsSabotage DNA or RNA. Fluoroquinolones jam DNA gyrase. Rifampicin blocks RNA polymerase. Metronidazole creates DNA-damaging radicals (only in anaerobes).
Family 4
Folate synthesisStarve bacteria of folate (they make their own; we eat ours). Sulfonamides + trimethoprim hit two sequential steps — synergy. Dapsone is a sulfa cousin.
Family 5
Cell membrane / otherDaptomycin punctures the Gram+ membrane. The "last-resort Gram+" drugs (linezolid, synercid, tigecycline) also live here conceptually — drugs you reach for when everything else has failed.
§ 02Reading the drug names
Drug-class suffixes are the cheapest possible memory trick. Five of them cover most of the book:
| –cillin | penicillin family (peni-, methi-, oxa-, ampi-, amoxi-, ticar-) |
| cef–/ceph– | cephalosporins (cefotaxime, ceftriaxone, cefoxitin, cephalothin) |
| –cycline | tetracyclines (tetra-, doxy-, tige-) |
| –thromycin | macrolides (ery-, azi-, clari-) |
| –floxacin | fluoroquinolones (cipro-, ofl-, lev-) |
Watch out: –mycin alone is unreliable — gentamicin and streptomycin are aminoglycosides, but vancomycin is a glycopeptide and erythromycin is a macrolide. Use the rest of the stem (gent-, vanco-, eryth-).
§ 03β-Lactams — penicillins, cephalosporins, carbapenems
Penicillins –cillin
Bind penicillin-binding proteins (PBPs) → block peptidoglycan cross-linking → bacterium lyses. Bactericidal. Broken by β-lactamase.
| Drug | Textbook bugs | Role |
|---|---|---|
| Penicillin Gnatural penicillin · IV/IM | Str. pyogenes, Str. agalactiae, viridans, Str. pneumoniae (historical), diphtheria (clears bacilli), tetanus (clears bacilli), gas gangrene (with metronidazole), meningococci, T. pallidum, Borrelia (Lyme & relapsing), Leptospira, actinomycosis (6–12 mo), Bartonella bacilliformis | DOC for Group A strep, syphilis, actinomycosis, Lyme, leptospirosis. COMBO for gas gangrene (+ metronidazole). Adjunct in tetanus/diphtheria (kills bug, antitoxin handles disease). |
| Benzathine penicillindepot · monthly IM | Group A strep — rheumatic fever prophylaxis | PROPHYLAXIS Monthly injection for years post-RF to prevent recurrence. |
| Methicillin / Oxacillinβ-lactamase–resistant penicillins | S. aureus (β-lactamase producers — ~90% of clinical isolates) | 1st choice for non-MRSA S. aureus. MRSA (~20%) defeats them via altered PBPs → must escalate to vancomycin. |
| Ampicillinaminopenicillin · oral/IV | Listeria monocytogenes (+ gentamicin), Salmonella (typhoid + carriers), Shigella, severe Yersinia pseudotuberculosis; B. fragilis only when paired with sulbactam | DOC for listeriosis (+ gent in fulminant cases). Used for typhoid (+ MDR concerns), bacillary dysentery. K. pneumoniae is intrinsically resistant. |
| Amoxicillinaminopenicillin · oral | H. pylori (component of triple therapy) | TRIPLE With PPI + clarithromycin or metronidazole — 1 week regimen. |
| Ticarcillinextended-spectrum penicillin | B. fragilis (paired with clavulanate) | COMBO Ticarcillin + clavulanate covers β-lactamase-producing anaerobes. |
| Clavulanate / Sulbactamβ-lactamase inhibitors (not antibiotics alone) | Add-ons that protect any β-lactam from β-lactamase — used with ticarcillin or ampicillin for B. fragilis | ADJUNCT Only useful paired with a real β-lactam. Restores efficacy against β-lactamase producers. |
Cephalosporins cef– / ceph–
Same mechanism as penicillins (block PBPs) — but more stable against many β-lactamases. Bactericidal. Five generations; the textbook uses mostly 1st, 2nd & 3rd.
| Drug | Textbook bugs | Role |
|---|---|---|
| Cephalothin1st gen | Yersinia — listed only as resistant (PenG, ampicillin, cephalothin all fail) | Resistance marker Mentioned to flag that 1st-gen cephs don't cover Yersinia. |
| Cefoxitin2nd gen (cephamycin) | Bacteroides fragilis — surgical prophylaxis | PRE-OP Recommended preoperatively to prevent Bacteroides contamination of surgical wounds. |
| Cefotaxime / Ceftriaxone3rd gen · IV · cross BBB | Meningococcal meningitis, H. influenzae type b meningitis, gonorrhoea, H. ducreyi chancroid, severe Yersinia infections | DOC for gonorrhoea (ceftriaxone) and a meningitis first-line. COMBO with azithromycin in chancroid. |
| 3rd-gen cephalosporinsclass mention | Salmonella (typhoid), Shigella (bacillary dysentery) | Used alongside fluoroquinolones for MDR enterics. |
Carbapenems –penem
β-lactam with the broadest spectrum of any class. Resistant to almost all β-lactamases. Bactericidal.
| Drug | Textbook bugs | Role |
|---|---|---|
| Imipenem | Bacteroides fragilis | Effective Listed as one of the β-lactams that works against β-lactamase-producing B. fragilis. |
§ 04Glycopeptides
Glycopeptides vanco–
Bind D-Ala–D-Ala on peptidoglycan precursors → block cross-linking from a different angle than β-lactams. Bactericidal. The molecule is too bulky to cross the outer membrane of Gram-negatives — that's why vancomycin is a Gram-positive-only drug.
| Drug | Textbook bugs | Role |
|---|---|---|
| VancomycinIV systemic · ORAL only for C. diff | MRSA / ORSA S. aureus; S. epidermidis (DOC, plus rifampicin or gentamicin); penicillin-resistant S. pneumoniae ("the best"); oral therapy of C. difficile pseudomembranous colitis | DOC for MRSA and S. epidermidis. "Best" per textbook for resistant pneumococci. Alt. to metronidazole for C. difficile. |
§ 05Aminoglycosides
Aminoglycosides gent– · strep– · kana–
Bind 30S ribosomal subunit → cause misreading of mRNA → faulty proteins puncture the membrane. Bactericidal (rare for a protein-synthesis drug). Don't penetrate intact Gram-positive walls well — that's why they're almost always paired with a cell-wall drug.
| Drug | Textbook bugs | Role |
|---|---|---|
| Gentamicin | Listeria monocytogenes (+ ampicillin), P. aeruginosa serious infections (+ β-lactam), S. epidermidis (+ vancomycin), severe Yersinia infections, Y. pestis plague | COMBO Always paired. Never first-line monotherapy in the textbook. |
| Streptomycin | Brucella (+ tetracycline), Y. pestis plague, TB (1st line), Bartonella bacilliformis Oroya fever | COMBO for brucellosis. 1st-line in anti-TB regimen. |
| Kanamycin | M. tuberculosis — drug-resistant strains | 2nd-line TB Reserved for treatment failure or 1st-line resistance. |
§ 06Tetracyclines & glycylcyclines
Tetracyclines –cycline
Bind 30S → block aminoacyl-tRNA from docking → no peptide elongation. Bacteriostatic. Penetrate cells well — that's the secret to their oddball spectrum.
| Drug | Textbook bugs | Role |
|---|---|---|
| Tetracyclineparent compound | V. cholerae (shortens carriage), H. pylori (triple therapy option), Brucella (+ strep or rif), T. pallidum (penicillin allergy), Borrelia (Lyme, relapsing), Leptospira, Mycoplasma, Rickettsia group (typhus), Bartonella henselae; mentioned as resistance in B. fragilis | DOC for Rickettsia, Mycoplasma. Pen-allergy alt for syphilis. COMBO for brucellosis & H. pylori. |
| Doxycyclinelong-acting tetracycline | B. anthracis anthrax, B. cereus, Y. pestis plague (+ aminoglycoside for severe), Y. enterocolitica, R. typhi, R. rickettsii, Orientia tsutsugamushi, Coxiella burnetii Q fever, Chlamydia STD | DOC for Q fever, scrub typhus, Rocky Mountain spotted fever, anthrax (with ciprofloxacin as the other option). DOC for chlamydial STDs (alongside azithromycin). |
Glycylcyclines tige–
Structurally modified tetracycline — same 30S target, but evades the efflux pumps and ribosomal protection that defeat older tetracyclines. Bacteriostatic, broad-spectrum.
| Drug | Textbook bugs | Role |
|---|---|---|
| Tigecycline | Vancomycin-resistant enterococci (VRE) | Newer Listed alongside synercid, linezolid, daptomycin for VRE. |
§ 07Macrolides
Macrolides –thromycin
Bind 50S subunit → block translocation of growing peptide chain. Bacteriostatic. Concentrate inside cells — like tetracyclines, they reach intracellular bugs.
| Drug | Textbook bugs | Role |
|---|---|---|
| Erythromycin | Str. pyogenes (pen allergy), diphtheria (clears bacilli & contacts), Bordetella pertussis, B. cereus, Campylobacter jejuni, atypical pneumonia (Mycoplasma, Legionella, Chlamydia), syphilis (pen allergy), neonatal gonococcal conjunctivitis (ointment prevention), Bartonella, actinomycosis (pen allergy) | DOC for whooping cough. Pen-allergy alt across many strep/spirochete/Gram+ infections. Prophylaxis for pertussis contacts and neonatal gonococcal eye infection. |
| Azithromycinlong t½ · often single-dose | N. gonorrhoeae co-treatment (covers concurrent Chlamydia), H. ducreyi chancroid (+ ceftriaxone), Chlamydia STD, Legionella, Mycoplasma | DOC for chlamydial STDs (single dose, alongside doxycycline). COMBO with ceftriaxone for chancroid. |
| Clarithromycin | Helicobacter pylori | TRIPLE PPI + amoxicillin + clarithromycin, 1 week regimen. |
§ 08Lincosamides
Lincosamides clinda–
Bind 50S at the same site as macrolides → block peptide bond formation. Bacteriostatic. Penetrates abscesses and bone well — that's its niche.
| Drug | Textbook bugs | Role |
|---|---|---|
| Clindamycin | Bacteroides fragilis; actinomycosis (penicillin-allergic patients) | Used for B. fragilis ("most strains susceptible"). Pen-allergy alt for actinomycosis. |
§ 09Chloramphenicol
Chloramphenicol chlor–
Binds 50S → blocks peptidyl transferase. Bacteriostatic, broad-spectrum. Limited by the well-known toxicity (bone-marrow suppression, "grey baby syndrome") — so reserved.
| Drug | Textbook bugs | Role |
|---|---|---|
| Chloramphenicol | Meningococci (when β-lactam resistance suspected), Salmonella (typhoid), severe Yersinia, R. prowazekii epidemic typhus, R. typhi endemic typhus, Bartonella bacilliformis | Reserve Used when 1st-line options fail or are contraindicated. |
§ 10Fluoroquinolones
Fluoroquinolones –floxacin
Inhibit bacterial DNA gyrase (topoisomerase II) and topoisomerase IV → DNA can't unwind for replication. Bactericidal. Excellent oral bioavailability, broad-spectrum, penetrates secretions (saliva, prostate).
| Drug | Textbook bugs | Role |
|---|---|---|
| Ciprofloxacin | B. anthracis anthrax, B. cereus, Salmonella (chronic carriers), Shigella bacillary dysentery, Y. pestis plague, Y. enterocolitica, Campylobacter jejuni, meningococcal chemoprophylaxis, MDR/XDR-TB (2nd line) | DOC for anthrax. Chemoprophylaxis for meningococcal contacts (saliva secretion). 2nd-line TB. |
| Fluoroquinolonesclass mention — implies cipro, levo, etc. | Penicillin-resistant S. pneumoniae, Salmonella, severe Yersinia, Legionella Legionnaires' disease | First-line alternative for Legionella alongside macrolides. Effective against penicillin-resistant pneumococci. |
§ 11Rifamycins
Rifamycins rifa–
Block bacterial DNA-dependent RNA polymerase → no transcription, no proteins. Bactericidal. Penetrates everywhere — abscesses, CSF, intracellular bugs, even saliva.
| Drug | Textbook bugs | Role |
|---|---|---|
| Rifampicinaka rifampin | M. tuberculosis (1st-line, "the second major" antitubercular), M. leprae (+ dapsone), Brucella (+ tetracycline, alt. to streptomycin), S. epidermidis (+ vancomycin), meningococcal chemoprophylaxis (close contacts), H. influenzae nasal carriage | 1st-line TB. COMBO in every use case (never solo — resistance). Chemoprophylaxis for meningococcal contacts. |
§ 12Nitroimidazoles
Nitroimidazoles metro–
A prodrug: only the reducing environment inside anaerobes activates it. Once activated, it generates radicals that fragment bacterial DNA. Bactericidal — but only in anaerobes / microaerophilic bugs.
| Drug | Textbook bugs | Role |
|---|---|---|
| Metronidazole | C. difficile pseudomembranous colitis (oral), C. perfringens gas gangrene (+ penicillin), B. fragilis, H. pylori (triple therapy), Gardnerella vaginalis bacterial vaginosis | DOC for C. difficile and bacterial vaginosis. DOC for B. fragilis ("most strains susceptible"). COMBO for gas gangrene & H. pylori. |
§ 13Folate-synthesis inhibitors
Sulfonamides + Trimethoprim SXT / co-trimoxazole
Bacteria must make their own folate (we eat ours). Sulfa blocks PABA → DHF; Trimethoprim blocks DHF → THF. Two sequential blocks of the same pathway = synergy, bactericidal in combination.
| Drug | Textbook bugs | Role |
|---|---|---|
| Trimethoprim-sulfamethoxazoleSXT · TMP-SMX · co-trimoxazole | Nocardia (DOC), Listeria monocytogenes (with ampicillin), Salmonella typhoid & chronic carriers, severe Yersinia infections | DOC for nocardiosis. Alternative for listeriosis, typhoid, complex Yersinia. |
Sulphones dap–
Structural cousin of sulfonamides — same folate-blocking mechanism, with a special place in mycobacterial therapy.
| Drug | Textbook bugs | Role |
|---|---|---|
| Dapsonesulphone | M. leprae — leprosy | Main agent for leprosy, combined with rifampicin to prevent resistance. |
§ 14Last-resort Gram-positive arsenal
The textbook lumps these together as "newer antibiotics" for MRSA and VRE — bugs that have defeated vancomycin or the wider Gram-positive arsenal. Different classes, same purpose.
Oxazolidinones linez–
Bind 50S at a unique site → block initiation of protein synthesis (no other class does this). Bacteriostatic.
| Drug | Textbook bugs | Role |
|---|---|---|
| Linezolid | MRSA S. aureus, vancomycin-resistant enterococci (VRE) | Newer Listed as available for resistant strains. |
Streptogramins synercid
Two drugs that synergise on the 50S — together they're bactericidal; each one alone is only bacteriostatic.
| Drug | Textbook bugs | Role |
|---|---|---|
| Quinupristin/dalfopristinSynercid · fixed combination | MRSA, VRE | Newer For multidrug-resistant Gram+ infections. |
Lipopeptides dapto–
Insert into the Gram-positive cell membrane → form pores → depolarisation → rapid death. Bactericidal. Doesn't work in lung tissue (inactivated by surfactant — a useful trivia point).
| Drug | Textbook bugs | Role |
|---|---|---|
| Daptomycin | MRSA S. aureus, VRE | Newer Listed for resistant Gram-positive infections. |
§ 15Anti-tubercular drugs
First-line TB drugs RIPES
A multidrug regimen is mandatory — single-drug therapy guarantees resistance because M. tuberculosis divides slowly and persists intracellularly. Duration: 6–12 months. Sputum becomes non-infectious within 2–3 weeks of starting.
| Drug | Mechanism (one line) | Role |
|---|---|---|
| Isoniazid (INH) | Blocks mycolic acid synthesis (the wax in the mycobacterial wall) | 1st · "the major" |
| Rifampicin | Blocks bacterial RNA polymerase (see § 11) | 1st · "the second major" |
| Pyrazinamide | Activated in the acidic phagolysosome — kills intracellular dormant bacilli | 1st |
| Ethambutol | Blocks arabinogalactan synthesis (cell wall component) | 1st |
| Streptomycin | Aminoglycoside — 30S misreading (see § 05) | 1st |
Second-line TB drugs resistance / failure
More toxic, less effective. Brought in only when first-line drugs fail or resistance has emerged.
| Drug | Class / mechanism | Role |
|---|---|---|
| Ethionamide | Structural analogue of INH — blocks mycolic acid synthesis | 2nd-line |
| Kanamycin | Aminoglycoside (30S) | 2nd-line |
| Capreomycin | Polypeptide — inhibits protein synthesis | 2nd-line |
| Cycloserine | Blocks D-alanine incorporation into peptidoglycan (cell wall) | 2nd-line |
| Fluoroquinolonese.g. ciprofloxacin | DNA gyrase inhibitor (see § 10) | 2nd-line |
§ 16Topical agents
Mupirocin mupi–
Inhibits bacterial isoleucyl-tRNA synthetase → no protein synthesis. Used topically because it's inactivated quickly when systemic.
| Drug | Textbook use | Role |
|---|---|---|
| Mupirocinintranasal ointment | S. aureus — nasal decolonisation | Topical |
§ 17Clinical-syndrome panels
The textbook builds five combination regimens worth memorising as whole patterns — not just lists of drugs. These come up repeatedly in exam questions.
M. tuberculosis — first-line regimen
- Duration: 6–12 months
- Sputum becomes non-infectious: 2–3 weeks after start
- MDR-TB: resistance to isoniazid and rifampicin (the two majors)
- XDR-TB: MDR + resistance to any fluoroquinolone + ≥3 second-line drugs
- Why multi-drug? Single-drug therapy guarantees resistance during the long treatment duration
H. pylori — triple therapy (1–2 weeks → 95% eradication)
- Alternative regimen: Bismuth salt + metronidazole + (amoxicillin OR tetracycline) for 14 days
- Why three drugs? Eradication rates with single drugs are too low because H. pylori sits in mucus and is hard to reach
MRSA / VRE — the resistant-Gram+ arsenal
- MRSA S. aureus: vancomycin (DOC). Newer options: linezolid, daptomycin, quinupristin/dalfopristin.
- S. epidermidis: vancomycin + (rifampicin OR gentamicin). Especially important in prosthetic/catheter infections.
- VRE (vancomycin-resistant enterococci): quinupristin/dalfopristin · linezolid · daptomycin · tigecycline.
- Pen-resistant S. pneumoniae: New cephalosporins, fluoroquinolones — but textbook says "vancomycin is the best."
Anaerobic infections — the metronidazole + clindamycin domain
- B. fragilis: Mainstay: drainage + debridement. Antibiotics: clindamycin or metronidazole (most strains susceptible). Reserves: imipenem, ticarcillin + clavulanate, ampicillin + sulbactam. Pre-op cover: cefoxitin. Note: resistant to most cephalosporins and tetracyclines.
- Gas gangrene (C. perfringens): Surgery + hyperbaric O₂ + penicillin + metronidazole.
- C. difficile: Step 1: stop the offending antibiotic (cephalosporins / FQs / clindamycin / β-lactam-inhibitors / macrolides are the classic triggers). Step 2: oral metronidazole or vancomycin.
Penicillin-allergy substitutes (recurring textbook pattern)
- Group A strep (Str. pyogenes): erythromycin
- Syphilis (T. pallidum): tetracycline or erythromycin
- Actinomycosis: clindamycin or erythromycin
- The pattern: macrolides are the default penicillin substitute when an oral, broad Gram-positive option is needed. Tetracyclines step in for spirochetes.
§ 18Bug → Drug cross-index
Reverse lookup, grouped by the same categories as your master table. Roles shown only where the textbook is explicit. DOC = drug of choice · 1st = first-line · ALT = alternative · COMBO = always part of a combination · CHEMO = chemoprophylaxis · 2nd = second-line.
Gram-positive cocci
| Organism | Drugs (textbook-stated hierarchy) |
|---|---|
| S. aureus methicillin-susceptible (~90%) | 1st Methicillin / oxacillin · cephalosporins · vancomycin |
| S. aureus MRSA / ORSA | DOC Vancomycin · Newer: linezolid, daptomycin, quinupristin/dalfopristin · Nasal carriage: mupirocin |
| S. epidermidis | DOC Vancomycin + + rifampicin OR gentamicin |
| Str. pyogenes Group A β-haemolytic | DOC Penicillin · Pen-allergy: erythromycin · RF prophylaxis: benzathine penicillin (monthly) |
| Str. pneumoniae | Historical: penicillin (now resistance prevalent) · Effective: new cephalosporins, fluoroquinolones · "Best": vancomycin |
| Enterococci VRE | Resistant to penicillins & aminoglycosides. Newer: quinupristin/dalfopristin · linezolid · daptomycin · tigecycline |
Gram-negative cocci — Neisseriae
| N. gonorrhoeae | DOC Ceftriaxone + tetracycline OR azithromycin (cover concurrent Chlamydia, 50% co-infection) · Newborn eye prophylaxis: erythromycin ointment |
| N. meningitidis | 1st IV penicillin G or ceftriaxone (immediately) · Resistance: chloramphenicol · Chemoprophylaxis of contacts: rifampicin OR ciprofloxacin (saliva-penetrating) |
Gram-positive bacilli — aerobic
| Corynebacterium diphtheriae | Critical: diphtheria antitoxin (neutralises circulating toxin) · + penicillin OR erythromycin (clears bacilli) · Contacts: erythromycin / long-acting penicillin |
| Listeria monocytogenes | DOC Ampicillin + gentamicin · Alt: ampicillin + SXT · Gastroenteritis: usually no treatment |
| Bacillus anthracis | DOC Ciprofloxacin or doxycycline |
| Bacillus cereus | Resistant to penicillin (β-lactamase). Alternatives: doxycycline, erythromycin, ciprofloxacin |
Gram-positive bacilli — anaerobic (Clostridia)
| C. tetani | Primary: human tetanus immune globulin + booster toxoid · + penicillin (clears bacilli) · wound care · muscle relaxants |
| C. perfringens gas gangrene | Mainstay: surgical debridement + hyperbaric O₂ · + penicillin + metronidazole |
| C. difficile | Step 1: stop offending antibiotic · Step 2: oral metronidazole OR vancomycin |
Gram-negative bacilli — Enterobacteriaceae
| E. coli extra-intestinal | Empirical: guided by AST due to resistance. Diarrhoea: rehydration ± selected antibiotics |
| Klebsiella pneumoniae | Intrinsically resistant to ampicillin. ESBL → resists most cephalosporins → routine in vitro AST required |
| Proteus spp. | Per AST — resistant to many drugs |
| Salmonella typhoid / enteric fever | 1st: chloramphenicol · ampicillin · SXT · fluoroquinolones · 3rd-gen cephalosporins (per AST — MDR is the rule). Chronic carriers: ampicillin · SXT · ciprofloxacin (cholecystectomy if gall bladder disease) |
| Shigella | Mainstay: fluid + electrolyte replacement · + ampicillin · ciprofloxacin · 3rd-gen cephalosporins (shortens illness) |
Gram-negative bacilli — non-fermenters
| Pseudomonas aeruginosa | Resistant to many drugs → AST required. Serious infections: β-lactam + aminoglycoside |
| Acinetobacter spp. | Often highly resistant. AST-guided therapy only |
Curved Gram-negative bacilli
| Vibrio cholerae | Mainstay: IV fluid + electrolyte correction · + tetracycline (shortens shedding) |
| Campylobacter jejuni | Rehydration ± erythromycin or ciprofloxacin (severe cases only) |
| Helicobacter pylori | TRIPLE THERAPY: PPI + amoxicillin + (clarithromycin OR metronidazole) for 1 week. Alt: bismuth + metronidazole + (amoxicillin OR tetracycline) × 14 days |
Fastidious / zoonotic Gram-negatives
| Haemophilus influenzae type b meningitis | DOC Cefotaxime OR ceftriaxone · + steroids 15–20 min pre-antibiotic (limits inflammatory neurologic damage) · Nasal carriage / contacts: rifampicin |
| Haemophilus ducreyi chancroid | Macrolide (azithromycin) + 3rd-gen cephalosporin (ceftriaxone) |
| Bordetella pertussis | DOC Erythromycin · Exposed unimmunized: erythromycin |
| Brucella spp. | Prolonged combo: tetracycline + (streptomycin OR rifampicin) |
| Yersinia pestis plague | Early therapy critical: tetracyclines (doxycycline) · fluoroquinolones (ciprofloxacin) · aminoglycosides (streptomycin / gentamicin) |
| Yersinia enterocolitica | Mild: self-limiting. Severe: doxycycline + aminoglycoside · alts: SXT · ceftriaxone · FQs · chloramphenicol. Resistant to penicillin G, ampicillin, cephalothin. |
| Bacteroides fragilis | Drainage + debridement primary. Most strains: clindamycin OR metronidazole. β-lactam reserves: imipenem · ticarcillin/clavulanate · ampicillin/sulbactam. Pre-op: cefoxitin. Resistant: most cephs, tetracycline |
| Legionella pneumophila | DOC Macrolides (erythromycin, azithromycin) OR fluoroquinolones |
Mycobacteria
| M. tuberculosis | 1st-line: Isoniazid + Rifampicin + Pyrazinamide + Ethambutol + Streptomycin (RIPES) · 6–12 months · 2nd-line: ethionamide · kanamycin · capreomycin · cycloserine · fluoroquinolones |
| M. leprae | Main agent: dapsone + rifampicin (prevent resistance) · until lesions organism-free (≥ 2 years) |
Spirochetes
| Treponema pallidum syphilis | DOC Penicillin · Pen-allergy: tetracycline OR erythromycin |
| Borrelia burgdorferi Lyme disease | Tetracyclines · penicillin |
| Borrelia recurrentis & B. duttoni relapsing fever | Penicillin · tetracyclines |
| Leptospira interrogans | Penicillin · tetracyclines |
Wall-less & obligate intracellular
| Mycoplasma spp. | Tetracyclines · macrolides (erythromycin, azithromycin). β-lactams useless (no cell wall) |
| Rickettsia prowazekii epidemic typhus | Tetracycline · chloramphenicol |
| Rickettsia typhi endemic typhus | Doxycycline · chloramphenicol |
| Rickettsia rickettsii RMSF | Doxycycline |
| Orientia tsutsugamushi scrub typhus | Doxycycline |
| Coxiella burnetii Q fever | DOC Doxycycline |
| Chlamydia trachomatis STD serotypes D–K | DOC Doxycycline OR azithromycin · treat partners |
| Chlamydophila psittaci / pneumoniae | Tetracycline · erythromycin |
Minor pathogens & fungus-like bacteria
| Gardnerella vaginalis bacterial vaginosis | DOC Metronidazole |
| Bartonella bacilliformis Oroya fever | Penicillin · streptomycin · chloramphenicol |
| Bartonella henselae cat-scratch disease | Supportive primarily · tetracycline or erythromycin may help |
| Actinomyces actinomycosis | DOC Surgical drainage + penicillin G × 6–12 months · Pen-allergy: clindamycin OR erythromycin |
| Nocardia nocardiosis | DOC Trimethoprim-sulfamethoxazole |
| Actinomycotic mycetoma | Surgical drainage + debridement + antimicrobials (responds well, unlike eumycotic) |